Search

Your search keyword '"Patiromer -- Usage"' showing total 4 results
Start Over Descriptor "Patiromer -- Usage"
4 results on '"Patiromer -- Usage"'

1. Patiromer Use for Acute Hyperkalemia Characterized

Author

Persaud, Natasha

Subjects
Drug therapy, Usage, Patiromer -- Usage, Medical records -- Usage, Hyperkalemia -- Drug therapy
Abstract

Patiromer monotherapy may be effective for acute, non-life-threatening hyperkalemia, investigators reported at Kidney Week 2022, the annual meeting of the American Society of Nephrology. Use of https://www.empr.com/generic-drug/patiromer/ for chronic hyperkalemia [...]

Published
2022

2. Patiromer Use for Acute Hyperkalemia Characterized

Author

Persaud, Natasha

Subjects
Care and treatment, Usage, Patiromer -- Usage, Hyperkalemia -- Care and treatment
Abstract

Patiromer monotherapy may be effective for acute, non-life-threatening hyperkalemia, investigators reported at Kidney Week 2022, the annual meeting of the American Society of Nephrology. Use of patiromer for chronic hyperkalemia [...]

Published
2022

3. Reports from Bellvitge University Hospital Describe Recent Advances in Chronic Heart Failure (Use of potassium-binder patiromer for up-titration of renin-angiotensin-aldosterone system inhibition therapy in a patient with chronic heart failure ...)

Subjects
Care and treatment, Usage, Heart failure -- Care and treatment, Patiromer -- Usage, Physical fitness -- Usage, Sodium zirconium cyclosilicate -- Usage, Angiotensins -- Usage, Eplerenone -- Usage, Aldosterone -- Usage, Medical research -- Usage, Glucocorticoids -- Usage, Cardiac patients -- Care and treatment
Abstract

2020 OCT 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Heart Disorders and Diseases - Chronic Heart Failure [...]

Published
2020

4. First patient treated in DIAMOND study to evaluate if Veltassa(r) (patiromer) improves outcomes by enabling long-term use of essential RAASi therapy

Subjects
Patiromer -- Usage, Medical research -- Usage, Chronic kidney failure -- Patient outcomes -- Care and treatment -- Usage, Angiotensins, Kidney diseases, Aldosterone, Glucocorticoids, Heart failure, General interest, News, opinion and commentary, Veltassa (Medication) -- Usage
Abstract

ZURICH: Vifor Pharma has issued the following press release: Vifor Pharma today announced that treatment of the first patient in their global phase-IIIb DIAMOND study has begun. The study will [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results